Medication Use and Driving Risks by Tammie Lee Demler, BS Pharm, Pharmd

Total Page:16

File Type:pdf, Size:1020Kb

Medication Use and Driving Risks by Tammie Lee Demler, BS Pharm, Pharmd CONTINUING EDUCATION Medication Use and Driving Risks by Tammie Lee Demler, BS Pharm, PharmD pon successful completion of this ar- the influence of alcohol has Useful Websites ticle, pharmacists should be able to: long been accepted as one 1. Identify the key functional ele- of the most important causes ■ www.dot.gov/ or http://www.dot.gov/ ments that are required to ensure of traffic accidents and driv- odapc/ competent, safe driving. ing fatalities. Driving under Website of the U.S. Department of 2. Identify the side effects associated with pre- the influence of alcohol has Transportation, which contains trends Uscription, over-the-counter and herbal medi- been studied not only in ex- and law updates. It also contains an cations that can pose risks to drivers. perimental research, but also excellent search engine. 3. Describe the potential impact of certain medi- in epidemiological road side ■ www.mayoclinic.com/health/herbal- cation classes on driving competence. studies. The effort that society supplements/SA00044 4. Describe the pharmacist’s duty to warn re- has made to take serious le- Website for the Mayo Clinic, with garding medications that have the potential to gal action against those who information about herbal supplements. impair a patient’s driving competence. choose to drink and drive It offers an expert blog for further exploration about specific therapies and 5. Provide counseling points to support safe driv- has resulted in the significant to receive/share insight about personal ing in all patients who are receiving medication. deterrents of negative social driving impairment with herbal drugs. stigma and incarceration. ■ www.icadts.nl/ Upon successful completion of this article, phar- Recently, laws in some states Website of the International Council on macy technicians should be able to: were strengthened even fur- Alcohol, Drugs and Traffic Safety, which 1. Identify the key functional elements that are ther by making driving while works to reduce morbidity and mortality required to ensure competent, safe driving. intoxicated (DWI) a felony if brought about by use of alcohol and 2. List side effects associated with the use there is a child in the car. drugs by operators of vehicles using all of herbal remedies, over-the-counter and While the impact of modes of transportation. prescription medications that can pose risks alcohol on driving abilities to drivers. is well known, there are few 3. Describe the potential impact of certain medi- epidemiologic studies about the role of herbal remedies, cation classes on driving competence. over-the-counter and prescription drugs in motor vehicle 4. Describe situations when the pharmacist accidents. There are some lab experiments in which the should be alerted to counsel patients on the therapeutic doses of several drugs have been shown potential of a medication to impair driving to impair psychomotor skills related to driving. It is also competence. important to note that many medications may potentiate the impairing effects of alcohol and other drugs. Less INTRODUCTION attention has been given to driving under the influence We are all well aware of the impact of drink- of medication, whether prescription or OTC medication. ing and driving through the media coverage Illicit drug use also seems to receive less media attention of drinking related accidents and through the than alcohol, and is much more difficult to detect. Field public service announcements sponsored by sobriety tests and breathalyzer detection systems have law and advocacy groups. Driving while under been in place for some years to detect alcohol, but as yet www.americaspharmacist.net March 2012 | america’s PHARMACIST 35 there is no valid test to measure impairment from other severity of the effects differ between the medica- substances. Departments of motor vehicles (DMV) across tions studied, often depending on the half lives, the United States have tried to address this issue, and the dose, and formulation of the medications. New York state DMV medical advisory board tackled the There has been research looking at the issue of the impact of OTC medications on driving as a residual effects of benzodiazepines and non- specific focus of community outreach years ago. benzodiazepine hypnotics (z-hypnotics), using The issue of tracking the absolute impact of medi- single dose temazepam 20 mg and eszopiclone cations on driving is difficult unless there is an accident 7.5 mg in older drivers. Even though these two which requires further investigation and confirmatory medications would be expected to cause sig- blood tests that can be evaluated. The question remains, nificant residual side effects equally, the results however, whether appropriate use of herbal remedies and of the study do not support this hypothesis. The FDA approved medications poses a sufficiently significant study reported that single dose temazepam- potential hazard to suggest that these agents should not impaired driving performance in elderly patients be used while driving. Researchers must consider that the until 10 hours after bedtime administration, same dose of a certain medication can have wide vari- whereas eszopiclone impaired driving signifi- ability in both the intended therapeutic action of the drug, cantly until 11 hours after the dose. but also the side effects for individuals of different ages Antidepressants were evaluated for similar and states of health. People often drive without adequate effects. In a study of nefazodone, it was found knowledge of the degree of impairment their prescribed that impairment is the same for both elderly and and OTC medications can have on their driving skills. younger patients. It may be suggested that the Individual differences in the absorption, distribution, testing parameters may not have been sensitive metabolism and elimination of medications all cause enough to detect effects on specific features a difference in the effect of a drug on the body. As we of elderly drivers, especially when the same age, these differences become even more pronounced. medications have demonstrated moderate Coupled with the age-specific decline in physical and impairment in younger subjects. Some studies cognitive ability to drive and operate machinery, changes have examined the effects of chronic use versus of organ function and lean body mass can also play a role intermittent use of benzodiazepines with no dif- in driving deficits as we grow older. However, it is impor- ference noted, so caution should be extended tant to note that organ changes can be seen in younger even for those who use sedating medications on patients with chronic disease and comorbidities condi- a regular basis. tions as well. The impairment of behavioral, mental and Another factor to be considered is that while physical functions such as psychomotor performance, some drugs known to cause driving impairment visual perception, attention, memory and information pro- can be isolated and avoided, other substances cessing are all potential issues with medications. Aging which cause significant impairment are com- in itself is not the key to impairment. However, diseases bined with less impairing substances. Alcohol that are more likely to be experienced with increasing age, is known to impair driving, but also amplifies such as dementia and other medical comorbidities that what might be minor or insignificant impairment. can impact physical strength and executive function, are Multi-ingredient combinations may be perceived the real factors which must be considered as potential by the general population as less danger- contributions to decreased driving competence. With the ous products and sold to patients who would number of aging drivers expected to increase over time, otherwise not use the single source product. An these factors must be taken into account. One would example of this can be seen with OTC products expect that medications most commonly associated such as the combination of acetaminophen and with sedation, such as sleep medicines and/or sedative- diphenhydramine, which is marketed for pain hypnotics, would significantly increase risk. However, even relief at bedtime while improving sleep. The with these well-known offending drugs, the duration and diphenhydramine portion of this product is used 36 america’s PHARMACIST | March 2012 www.americaspharmacist.net alone as an OTC sleep aid. Other OTC medica- as being able to see a red light as a warning with discrete tions, such as anti-diarrheals, can also be very meaning when compared to a streetlight without meaning. sedating and impairing, so no medication should be considered entirely safe without consulting Visual Attention first with a health care professional. Another well- Visual attention is defined as the selection of visual stimuli studied category of impairing medication seen based on location in space. This is a key function for detect- prescribed in combination with other medica- ing road side targets, and impairment in this category can tions is the benzodiazepine class. Research be a reliable early indicator of many disorders including, but has demonstrated that use of multiple sedat- not limited to, dementia. Tests to determine the intactness of ing agents, such as duplicate benzodiazepine visual attention are available to specialists, however, are not therapy and benzodiazepines combined with widely available to most general practitioners. one or more antidepressants increases the risk Visual attention requires being able to pay attention of traffic
Recommended publications
  • Approach to Acute Ataxia in Childhood: Diagnosis and Evaluation Lalitha Sivaswamy, MD
    FEATURE Approach to Acute Ataxia in Childhood: Diagnosis and Evaluation Lalitha Sivaswamy, MD opsoclonus myoclonus ataxia syndrome, must receive special mention because the underlying disease process may be ame- nable to surgical intervention. In the tod- dler- and school-age groups, certain condi- tions (such as stroke and acute cerebellitis) require immediate recognition and imag- ing, whereas others (such as post-infec- tious ataxia and concussion) require close follow-up. Finally, mention must be made of diseases outside of the central nervous system that can present with ataxia, such as Guillain-Barré syndrome. he word ataxia is derived from the Greek word ataktos, which T means “lack of order.” Ataxia is characterized by disturbances in the voluntary coordination of posture and movement. In children, it is most prominent during walking (the sine qua non being a staggering gait with impaired tandem), but it can also be present during sitting or standing, or © Shutterstock when the child is performing move- Abstract Lalitha Sivaswamy, MD, is Associate Profes- ments of the arms, legs, or eyes. sor of Pediatrics and Neurology, Department Ataxia refers to motor incoordination that is This review focuses on the etiol- of Neurology, Wayne State University School of usually most prominent during movement ogy and diagnostic considerations for Medicine; and Medical Director, Headache Clinic, or when a child is attempting to maintain a acute ataxia, which for the purposes of Children’s Hospital of Michigan. sitting posture. The first part of the review this discussion refers to ataxia with a Address correspondence to: Lalitha Sivas- focuses on the anatomic localization of symptom evolution time of less than wamy, MD, Department of Neurology, Wayne ataxia — both within the nervous system 72 hours.1 State University School of Medicine, Children’s and without — using a combination of his- Motor coordination requires sensory Hospital of Michigan, 3901 Beaubien, Detroit, MI torical features and physical findings.
    [Show full text]
  • Scientific Opinion
    SCIENTIFIC OPINION ADOPTED: DD Month YEAR doi:10.2903/j.efsa.20YY.NNNN 1 Evaluation of the health risks related to the 2 presence of cyanogenic glycosides in foods other than raw 3 apricot kernels 4 5 EFSA Panel on Contaminants in the Food Chain (CONTAM), 6 Margherita Bignami, Laurent Bodin, James Kevin Chipman, Jesús del Mazo, Bettina Grasl- 7 Kraupp, Christer Hogstrand, Laurentius (Ron) Hoogenboom, Jean-Charles Leblanc, Carlo 8 Stefano Nebbia, Elsa Nielsen, Evangelia Ntzani, Annette Petersen, Salomon Sand, Dieter 9 Schrenk, Christiane Vleminckx, Heather Wallace, Diane Benford, Leon Brimer, Francesca 10 Romana Mancini, Manfred Metzler, Barbara Viviani, Andrea Altieri, Davide Arcella, Hans 11 Steinkellner and Tanja Schwerdtle 12 Abstract 13 In 2016, the EFSA CONTAM Panel published a scientific opinion on the acute health risks related to 14 the presence of cyanogenic glycosides (CNGs) in raw apricot kernels in which an acute reference dose 15 (ARfD) of 20 µg/kg bw was established for cyanide (CN). In the present opinion, the CONTAM Panel 16 concluded that this ARfD is applicable for acute effects of CN regardless the dietary source. Estimated 17 mean acute dietary exposures to cyanide from foods containing CNGs did not exceed the ARfD in any 18 age group. At the 95th percentile, the ARfD was exceeded up to about 2.5-fold in some surveys for 19 children and adolescent age groups. The main contributors to exposures were biscuits, juice or nectar 20 and pastries and cakes that could potentially contain CNGs. Taking into account the conservatism in 21 the exposure assessment and in derivation of the ARfD, it is unlikely that this estimated exceedance 22 would result in adverse effects.
    [Show full text]
  • Alcohol Sensitivity As an Endophenotype of Alcohol Use Disorder: Exploring Its Translational Utility Between Rodents and Humans
    brain sciences Review Alcohol Sensitivity as an Endophenotype of Alcohol Use Disorder: Exploring Its Translational Utility between Rodents and Humans Clarissa C. Parker 1,*, Ryan Lusk 2 and Laura M. Saba 2,* 1 Department of Psychology and Program in Neuroscience, Middlebury College, Middlebury, VT 05753, USA 2 Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; [email protected] * Correspondence: [email protected] (C.C.P.); [email protected] (L.M.S.) Received: 3 September 2020; Accepted: 9 October 2020; Published: 13 October 2020 Abstract: Alcohol use disorder (AUD) is a complex, chronic, relapsing disorder with multiple interacting genetic and environmental influences. Numerous studies have verified the influence of genetics on AUD, yet the underlying biological pathways remain unknown. One strategy to interrogate complex diseases is the use of endophenotypes, which deconstruct current diagnostic categories into component traits that may be more amenable to genetic research. In this review, we explore how an endophenotype such as sensitivity to alcohol can be used in conjunction with rodent models to provide mechanistic insights into AUD. We evaluate three alcohol sensitivity endophenotypes (stimulation, intoxication, and aversion) for their translatability across human and rodent research by examining the underlying neurobiology and its relationship to consumption and AUD. We show examples in which results gleaned from rodents are successfully integrated with information from human studies to gain insight in the genetic underpinnings of AUD and AUD-related endophenotypes. Finally, we identify areas for future translational research that could greatly expand our knowledge of the biological and molecular aspects of the transition to AUD with the broad hope of finding better ways to treat this devastating disorder.
    [Show full text]
  • Mechanisms of Ethanol-Induced Cerebellar Ataxia: Underpinnings of Neuronal Death in the Cerebellum
    International Journal of Environmental Research and Public Health Review Mechanisms of Ethanol-Induced Cerebellar Ataxia: Underpinnings of Neuronal Death in the Cerebellum Hiroshi Mitoma 1,* , Mario Manto 2,3 and Aasef G. Shaikh 4 1 Medical Education Promotion Center, Tokyo Medical University, Tokyo 160-0023, Japan 2 Unité des Ataxies Cérébelleuses, Service de Neurologie, CHU-Charleroi, 6000 Charleroi, Belgium; [email protected] 3 Service des Neurosciences, University of Mons, 7000 Mons, Belgium 4 Louis Stokes Cleveland VA Medical Center, University Hospitals Cleveland Medical Center, Cleveland, OH 44022, USA; [email protected] * Correspondence: [email protected] Abstract: Ethanol consumption remains a major concern at a world scale in terms of transient or irreversible neurological consequences, with motor, cognitive, or social consequences. Cerebellum is particularly vulnerable to ethanol, both during development and at the adult stage. In adults, chronic alcoholism elicits, in particular, cerebellar vermis atrophy, the anterior lobe of the cerebellum being highly vulnerable. Alcohol-dependent patients develop gait ataxia and lower limb postural tremor. Prenatal exposure to ethanol causes fetal alcohol spectrum disorder (FASD), characterized by permanent congenital disabilities in both motor and cognitive domains, including deficits in general intelligence, attention, executive function, language, memory, visual perception, and commu- nication/social skills. Children with FASD show volume deficits in the anterior lobules related to sensorimotor functions (Lobules I, II, IV, V, and VI), and lobules related to cognitive functions (Crus II and Lobule VIIB). Various mechanisms underlie ethanol-induced cell death, with oxidative stress and Citation: Mitoma, H.; Manto, M.; Shaikh, A.G. Mechanisms of endoplasmic reticulum (ER) stress being the main pro-apoptotic mechanisms in alcohol abuse and Ethanol-Induced Cerebellar Ataxia: FASD.
    [Show full text]
  • Safety Tips & More
    #thankatrucker T Trusted IN THE R Responsible Safety Zone™ A Awesome Dedicated to Truck Driver Safety Awareness and Wellness JUNE 2020 n VOLUME 13 n ISSUE NO. 3 N Necessary D Dedicated S Safe R Road Warriors Congratulations to Douglas King, F Frontline Heroes I Indispensable TransForce Driver of the Year! O On the Road for Us V Vital n exceptional driver and an employee that all companies would like to have when it comes to R Respected E Efficient “A his work ethics!” Those words were used by our customer, Fourteenth Avenue Cartage to describe Douglas C Conscientious R Reliable King, our Driver of the Year, who we are proud to feature in this issue of In the Safety Zone.™ E Essential S Selfless Winning the Driver of the Year Award here at TransForce is a big deal. Pitted against thousands of drivers, the competition is fierce. Doug has been with TransForce since 2002 and has been working with Fourteenth TransForce Driver Avenue Cartage since 2005. During Referral Program! those years, he has rarely missed a day and has been accident free. What TransForce needs more good drivers a remarkable achievement. When From left to right: David Broome (President and to fill local, regional and OTR openings. asked what his key to success was, CEO, TransForce Group), Paul Braswell (VP, Field he says he just follows the rules, tries Operations and Recruiting), Doug King (Driver of to stay safe and do everything right. the Year), Kimberly Castagnetta (EVP Marketing and Division President Compliance and Safety), We should all follow his lead.
    [Show full text]
  • Management of Alcohol Use Disorders: a Pocket Reference for Primary Care Providers
    Management of alcohol use disorders: A pocket reference for primary care providers Meldon Kahan, MD Edited by Kate Hardy, MSW and Sarah Clarke, PhD Acknowledgments Mentoring, Education, and Clinical Tools for Addiction: Primary Care–Hospital Integration (META:PHI) is an ongoing initiative to improve the experience of addiction care for both patients and providers. The purpose of this initiative is to set up and implement care pathways for addiction, foster mentoring relationships between addiction physicians and other health care providers, and create and disseminate educational materials for addiction care. This pocket guide is excerpted from Safe prescribing practices for addictive medications and management of substance use disorders in primary care: A pocket reference for primary care providers, a quick-reference tool for primary care providers to assist them in implementing best practices for prescribing potentially addictive medications and managing substance use disorders in primary care, endorsed by the College of Family Physicians of Canada. This excerpt is a guide to talking to patients about their alcohol use and managing at-risk drinking and alcohol use disorders. We thank those who have given feedback on this document: Dr. Mark Ben-Aron, Dr. Peter Butt, Dr. Delmar Donald, Dr. Mike Franklyn, Dr. Melissa Holowaty, Dr. Anita Srivastava, and three anonymous CFPC reviewers. We gratefully acknowledge funding and support from the following organizations: Adopting Research to Improve Care (Health Quality Ontario & Council of Academic Hospitals of Ontario) The College of Family Physicians of Canada Toronto Central Local Health Integration Network Women’s College Hospital Version date: December 19, 2017 © 2017 Women’s College Hospital All rights reserved.
    [Show full text]
  • Frustration, Aggression & Road Rage
    Always remember that the primary goal in defensive driving is to stay safe and live to drive another day. Frustration, Aggression The context in which frustration occurs Other road users are probably equally and Road Rage can determine both the nature and extent frustrated in traffic, perhaps more so. of our own resulting aggressive behavior. They may not be as prepared for traffic. There are also differences in people’s nat- Frustration occurs when someone or Be courteous and forgiving. Your ural propensities. Some drivers are something impedes your progress toward behavior may serve to reduce their content to mutter curses to themselves a goal. In the driving environment our goal levels of frustration and consequently while others are provoked to physical is to get to our destination as quickly and their levels of aggression and violence. Both personal attributes and as safely as possible. When other road risk-taking, thereby making the traffic situational factors can moderate our users interfere with our progress we environment safer for everyone, aggressive responses. become frustrated. In the driving environ- including you. ment, increases in aggression can have Some experts distinguish between Do not fret over people, conditions and deadly consequences. Frustration can aggressive driving and road rage. things that you cannot control. Choose lead to any or all of the following Aggressive driving is instrumental, that is, your battles wisely and save your aggressive behaviour: it serves to further progress toward a energy and emotions for situations that desired outcome when we are frustrated. Excessive speeding or street racing you can influence.
    [Show full text]
  • Ataxia Digest
    Ataxia Digest 2015 Vol. 2 News from the Johns Hopkins Ataxia Center 2016 What is Ataxia? Ataxia is typically defined as the presence of Regardless of the type of ataxia a person may have, it abnormal, uncoordinated movements. This term is is important for all individuals with ataxia to seek proper most often, but not always, used to describe a medical attention. For the vast majority of ataxias, a neurological symptom caused by dysfunction of the treatment or cure for the disease is not yet available, so cerebellum. The cerebellum is responsible for many the focus is on identifying symptoms related to or motor functions, including the coordination of caused by the ataxia. By identifying the symptoms of voluntary movements and the maintenance of balance ataxia it becomes possible to treat those symptoms and posture. through medication, physical therapy, exercise, other therapies and sometimes medications. Those with cerebellar ataxia often have an “ataxic” gait, which is walking The Johns Hopkins Ataxia Center has a that appears unsteady, uncoordinated multidisciplinary clinical team that is dedicated to and staggered. Other activities that helping those affected by ataxia. The center has trained require fine motor control like writing, specialist ranging from neurologists, nurses, reading, picking up objects, speaking rehabilitation specialists, genetic counselors, and many clearly and swallowing may be others. This edition of the Ataxia Digest will provide abnormal. Symptoms vary depending you with information on living with ataxia and the on the cause of the ataxia and are multidisciplinary center at Johns Hopkins. specific to each person. Letter from the Director Welcome to the second edition of the Ataxia Digest.
    [Show full text]
  • The Dentate Nucleus in Friedreich's Ataxia
    Gen_0701:Gen_0701.qxd 07 04 17 4:27 PM Page 1 Ge neratio ns The Official Publication of the National Ataxia Foundation Volume 35, Number 1 Spring 2007 The Dentate Nucleus in F riedre ich’ s Ataxia By Arnulf H. Koeppen, MD Research and Neurology Services, V. A. Medical Center, Albany, NY 12208 Friedreich’s ataxia (F RDA) affects several the small power packs that provide energy to organs, including heart, insulin-producing cells the cell in the form of adenosine triphosphate, of the pancreas, bones, peripheral nerves, spinal and the work by Dr. Lamarche and his collabo - cord, ganglia of the dorsal spinal roots, and a rators in Sherbrooke received renewed atten - specific area of the brain called the dentate tion. Indeed, the disease of the heart in FRDA nucleus. can be attributed, in some measure, to iron in Since the first description of this autosomal mitochondria. recessive ataxia by Nicholaus Friedreich in the At this time, there is no evidence that a simi - 19th century, most neurologists have consid - lar accumulation of iron occurs in the spinal ered FRDA a disease of the spinal cord. cord or its dorsal root ganglia. The normal Friedreich was aware of heart disease in his dentate nucleus of the cerebellum ( f ig. 1 on patients but thought that it was due to high page 2) contains abundant iron, possibly typhoid-like fever. making it especially vulnerable to frataxin In 1980, Dr. Jacques B. Lamarche and associ - deficiency in FRDA. The dentate nucleus is ates in Sherbrooke, Québec, Canada, discov - the main way-station for impulses leaving the ered minute iron-rich granules in heart muscle cerebellum.
    [Show full text]
  • Factors That Impact Driving
    LESSON PLAN Factors That Impact Driving NATIONAL HEALTH EDUCATION STANDARDS (NHES) 9-12 Standard 5: Students will analyze the influence of family, peers, culture, media, technology, and other factors on healthy behaviors. • 5.12.2 Determine the value of applying a thoughtful decision-making process in health-related situations. • 5.12.3 Justify when individual or collaborative decision-making is appropriate. • 5.12.4 Generate alternatives to health-related issues or problems. OBJECTIVES Your teen driver education objective is to help students make appropriate driving decisions by first analyzing how various factors impact teen driver safety. Students will achieve this objective by: • Explaining how speed affects teenage driving • Determining the impact of environmental conditions on teenage driving behaviors • Examining the effects of various mental and physical conditions on teenage driving behaviors • Determining the reasons people “take chances” when driving SPEEDING AND DRIVING 1. Have students list different speed limits they encounter while riding or driving in the car. 2. Ask students where they see lower speed limits (residential neighborhoods, etc.) versus where they have seen higher speed limits (highways). 3. Have students discuss the reasons for the variations in speed limits and ask them what might happen if there was just one speed limit, regardless of location. 4. Have students explain the importance of obeying speed limits and the dangers of not obeying speed limits. (cont. on page 2) 1 Do not conduct any activity without adult supervision. This content is provided for informational purposes only. Discovery Education and Toyota assume no liability for your use of the information. Copyright © 2018 Discovery Education.
    [Show full text]
  • Road Rage Factors
    ROAD RAGE FACTORS HOW TO AVOID ROAD RAGE Here are some common factors that often Make sure you have the right car insurance policy to contribute to road rage incidents or aggressive protect yourself from aggressive drivers or if you find driving behavior. yourself the victim of a road rage incident. TRAFFIC DELAYS BEFORE YOU GET BEHIND THE WHEEL o Heavy traffic, sitting at stoplights, looking for a o Don’t rush. Give yourself time to get where you’re parking space or even waiting for passengers going; you’re less likely to become impatient and can increase a driver’s anger level. take unnecessary risks. RUNNING LATE o Cool off. If you’re upset, take time to calm down. o Running behind for a meeting or appointment o Be aware and anticipate. If you expect can cause drivers to be impatient. something to happen you can sometimes resolve the issue before it occurs. ANONYMITY o If drivers feel that they probably won’t see WHAT TO REMEMBER WHEN DRIVING other drivers again, they may feel more o Give other drivers a break. If someone is driving comfortable engaging in risky driving slowly, keep in mind they might be lost. behaviors like tailgating, cutting people off, o Use hand gestures wisely. Keep gestures positive - excessive honking or making rude gestures. say, waving to a driver who lets you in when merging. o If the motoring public report these road o Don’t tailgate. Always keep a safe distance from rage incidents to our SEPI office, disciplinary the car in front, no matter how slowly they might measures could be taken with the employee.
    [Show full text]
  • Not to Be Disclosed to the Registrants of Hydrogen Cyanamide Formulations
    FORM HS1 Application for Reassessment of a Hazardous Substance under section 63 of the Hazardous Substances and New Organisms Act 1996 Name of Substance: Soluble concentrates containing Hydrogen Cyanamide (520 to 540 g/L) APPENDICES 2 to 11 Applicant: Chief Executive ERMA New Zealand Contents Appendix 2 – Class 1 to 8 Hazardous Properties Classification ............................................... 3 Appendix 3 - Class 9 - Hazardous Properties of Hydrogen Cyanamide and its Formulations 33 Appendix 4 - Overseas Case Studies on Human Exposure to Hydrogen Cyanamide ............. 46 Appendix 5 - NZKGI 0800 complaints for 2003 and 2004 ..................................................... 51 Appendix 6a - National Poisons Centre calls 1998-2001 ........................................................ 52 Appendix 6b - National Poisons Centre calls 2002-2005 ........................................................ 53 Appendix 7 - Toi Te Ora Public Health records of hydrogen cyanamide complaints 1998- 2004 ......................................................................................................................................... 64 Appendix 8 – Qualitative scales for describing effects ........................................................... 65 Appendix 9 – Human Health Exposure Modelling ................................................................. 68 Appendix 10 - Environmental Exposure Modelling ................................................................ 74 Application for Reassessment of Hydrogen Cyanamide: Appendices
    [Show full text]